NEW YORK, April 16, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Celgene Corporation ("Celgene") (NASDAQ:CELG) between September 12, 2016 and February 27, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:
http://www.zlk.com/pslra-d/celgene-corporation?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the trials for GED-0301 suffered from fatal design defects, such that GED-0301 had failed to demonstrate meaningful clinical efficacy; (3) the growth of Otezla sales had dramatically slowed during Celgene's third fiscal quarter of 2017; and (4) the clinical and nonclinical pharmacology data in Celgene's new drug application ("NDA") for Ozanimod were insufficient to permit a complete review by the FDA, which resulted in the FDA issuing a refusal to file letter to Celgene regarding the NDA.
If you suffered a loss in Celgene you have until May 29, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Mercer International Stock Surges 45% on C$20 Million Canada Funding
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Street Poller Media and The Boom of the Street Interview Ad Industry
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Toyota Global Sales Fall as China Demand Slumps
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 



